Patel Bhaumik B, Mohamed Anwar N, Schiffer Charles A
Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Internal Medicine, Division of Hematology-Oncology, Karmanos Cancer Institute, 4HW-4238, 4100 John R, Detroit, MI 48201, USA.
Leuk Res. 2006 Feb;30(2):225-32. doi: 10.1016/j.leukres.2005.06.008. Epub 2005 Aug 1.
We describe two patients with CML blast crisis with clonal evolution affecting 16q22 (t(16;16)(p13;q22) and inv(16)(p13;q22), abnormalities of core binding factor, usually found in de novo acute myeloid leukemia (AML)). The bone marrow of both cases showed myelomonocytic (M4) differentiation and eosinophilia. Both patients had prominent extramedullary disease and had poor response to treatment. A literature search focused on patients with CML and additional chromosome changes more typical of AML, revealed that the morphology of the blasts correlated with the finding typical of the underlying "AML" cytogenetic abnormality and an overall very poor clinical outcome, even in the groups with "favorable" AML type translocations.
我们描述了两名慢性粒细胞白血病急变期患者,其克隆进化影响16q22(t(16;16)(p13;q22)和inv(16)(p13;q22),即核心结合因子异常,通常见于原发性急性髓系白血病(AML))。两例患者的骨髓均显示髓单核细胞(M4)分化和嗜酸性粒细胞增多。两名患者均有明显的髓外病变,且对治疗反应不佳。一项针对慢性粒细胞白血病患者以及更典型的急性髓系白血病额外染色体改变的文献检索显示,原始细胞的形态与潜在“急性髓系白血病”细胞遗传学异常的典型发现相关,并且即使在具有“有利”急性髓系白血病类型易位的群体中,总体临床结局也非常差。